MARKET

CNCR

CNCR

Range Cancer Therapeutics ETF
NASDAQ
13.39
-0.86
-6.05%
Closed 16:00 11/15 EST
OPEN
14.25
PREV CLOSE
14.25
HIGH
14.25
LOW
13.39
VOLUME
5.62K
TURNOVER
0
52 WEEK HIGH
17.96
52 WEEK LOW
9.54
TOTAL ASSET
13.65M
YTD YIELD
38.72%
1D
5D
1M
3M
1Y
5Y
1D
The U.S. Shakes Up Global Pharma Supply Chains
Seeking Alpha · 3d ago
Why Healthcare Investors Shouldn't Bank On Drug Pipelines
Seeking Alpha · 4d ago
Weekly Report: what happened at CNCR last week (1104-1108)?
Weekly Report · 6d ago
What Trump's Win May Mean For The Markets And Economy
Seeking Alpha · 11/07 17:30
Weekly Report: what happened at CNCR last week (1028-1101)?
Weekly Report · 11/04 10:47
How The Outcome Of The U.S. Election Will Affect The Healthcare Sector
Seeking Alpha · 11/01 15:24
Weekly Report: what happened at CNCR last week (1021-1025)?
Weekly Report · 10/28 10:41
Managed Care Insurers See Wall Street Dip As Earnings Fall Short
Seeking Alpha · 10/26 04:35
More
Profile
Fund Name
Range Cancer Therapeutics ETF
Inception Date
2015-10-13
Benchmark
Loncar Cancer Immunotherapy TR USD
Advisor Company
Range Cancer
Custodian
U.S. Bank N.A
Manager
Rafael Zayas, Austin Wen, Andrew Serowik, Gabriel Tan, Todd Alberico, Brian Cooper